On the other hand, lack of a clinical response may represent tumours in which the priming or promotion of a nascent immune response is defective; this was addressed in a recent paper analysing the spatial relationships between CD8+ T‐cells and MHC class II‐expressing cells, most likely antigen‐presenting cells (APCs) [52]. The gene discussed is CD8A; the disease is neoplasm.